ASTH (ASTH)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$2.35B
EV / Sales0.67
EV / EBITDA14.43
EV / Operating Cash Flow14.15
EV / Free Cash Flow15.16

Return Metrics (TTM)

Return on Equity (ROE)3.88%
Return on Assets (ROA)1.28%
Return on Invested Capital (ROIC)3.23%
Return on Capital Employed (ROCE)5.36%

Yield Metrics

Earnings Yield1.74%
Free Cash Flow Yield8.79%

Balance Sheet Strength

Net Debt / EBITDA3.60
Current Ratio1.35
Working Capital$258.73M
Tangible Asset Value-$554.46M
Net Current Asset Value-$777.27M

Working Capital Efficiency

Days Sales Outstanding51.76
Days Payables Outstanding6.20
Operating Cycle (Days)51.76
Cash Conversion Cycle45.56

Capital Allocation

CapEx / Revenue0.31%
CapEx / Operating Cash Flow6.65%
R&D / Revenue0.00%
SG&A / Revenue6.67%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin9.30%
Operating Margin2.47%
Net Profit Margin0.71%

Solvency

Debt / Equity1.38
Quick Ratio1.40
Cash Ratio0.70

Per Share

Revenue / Share$64.83
FCF / Share$2.13
PE Ratio53.93